Cassidy takes aim at FDA mifepristone regulation, manufacturers

Cassidy takes aim at FDA mifepristone regulation, manufacturers

WASHINGTON (OSV News) — Sen. Bill Cassidy, R-La., chair of the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee, said in a report published Aug. 27 that while the FDA should reinstate the in-person dispensing requirement for mifepristone, its sponsors may not be “currently meeting their legal responsibilities to ensure compliance” with remaining requirements. Cassidy said the report was the result of an investigation into abor…